By Staff
Tuesday, November 19, 2024 12:24 AM
NEWARK, N.J.—Young men and women throughout our industry are playing key roles in all sectors of optical, including retailing, wholesaling, product design, manufacturing, distribution and vision care, often shaping the direction of the companies, practices and organizations where they work. In 2025,
Vision Monday will be highlighting this ambitious group of 30 Under 30 in our March issue as we spotlight these young voices who are already making their mark and changing the game of the eyewear/eyecare industry.
By Staff
Tuesday, November 19, 2024 12:21 AM
CHARLOTTE, N.C. and NEW YORK—Investment firms
Kian Capital Partners and
RF Investment Partners have announced the formation of US VisionMed Partners, a management services organization (MSO) supporting established, medically-focused optometry practices nationwide. The platform focuses on serving patients who may require more complex optometric care; its locations serve patients with an emphasis on specialty and medical services and products such as exams, diagnostic testing, dry eye treatments, vision therapy and myopia management.
By Staff
Tuesday, November 19, 2024 12:18 AM
NEW YORK—The
SUNY College of Optometry Foundation recognized 55 current students during the college’s annual scholarship presentation on November 13 with an audience of donors, students, alumni, parents and foundation board members. Hosted annually, the event brings together scholarship recipients and donors to celebrate academic achievement, dedication and philanthropy, according to the announcement.
By Staff
Tuesday, November 19, 2024 12:15 AM
MELBOURNE, Australia and PRINCETON, N.J.—
Opthea Limited (ASX/NASDAQ: OPT), a clinical-stage biopharmaceutical company developing therapies to treat prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), has announced the appointment of Kathy Connell, GAICD, to its board of directors as a non-executive director. Her appointment was effective immediately after the annual general meeting of the company on November 15, 2024, according to the announcement.
By Staff
Monday, November 18, 2024 12:27 AM
ALEXANDRIA, Va.—
The Vision Council has released its Market inSights Q3 2024 report featuring new market data and analysis estimating the performance of the $18.9 billion optical industry. The report reveals industry performance across a variety of categories, including eye exams, eyeglasses, frames, lenses, contact lenses, readers and plano sunglasses for the third quarter of 2024. “Compared to previous quarters of 2024, The Vision Council’s latest research shows a notable uptick in both the volume of prescription goods purchased and the value of these products and services, suggesting a strong back-to-school season for the industry,” said Alysse Henkel, vice president of research and inSights at The Vision Council.
By Staff
Monday, November 18, 2024 12:24 AM
LOS ANGELES—
DIFF Eyewear has appointed Roslyn Moody as the company's new director of sales. With over 25 years of experience in the optical industry, Moody has a proven track record in sales leadership, the company said.
By Staff
Monday, November 18, 2024 12:21 AM
IRVINE, Calif.—
Tarsus Pharmaceuticals, Inc., a company that applies proven science and new technology to improve treatments for patients, starting with eyecare, has announced the appointment of Katherine H. Goodrich, MD, MHS, chief medical officer of Humana Inc., to its board of directors.
By Staff
Monday, November 18, 2024 12:18 AM
VAUGHAN, Ontario—
Bausch + Lomb Corporation has announced its exclusive ONE by ONE Recycling and Biotrue Eye Care Recycling programs have collected a total of 94,119,275 units, or 569,743 pounds, of used contact lenses, eyecare and lens care materials in the U.S.
By Staff
Monday, November 18, 2024 12:15 AM
NEW YORK—
Jobson Research has issued a major update of a special report called "10 Years of Top U.S. Optical Retailer Trends." The special edition pulls together the last 10 years of Vision Monday's Top 50 U.S. Optical Retailers Reports and gauges the performance, expansion activity and estimated sales of the U.S. leading optical retailers and ECP groups over a 10-year period. It is designed to be a valuable resource and offer perspective on key trends and sales metrics. Derived from one of
Vision Monday's signature features, the VM Annual Top 50 U.S. Optical Retailers report, this new report has been compiled through a
Vision Monday/Jobson Research collaboration.
By Staff
Friday, November 15, 2024 12:30 AM
CHICAGO—
Prevent Blindness, an eye health and safety nonprofit, has declared November 18-24, 2024, as its fifth annual “Thyroid Eye Disease (TED) Awareness Week.” TED, also known as Graves’ Eye Disease or Graves’ ophthalmopathy, is an autoimmune disease in which the immune system causes inflammation and swelling, and stimulates the production of muscle tissue and fat behind the eye. This year’s TED Awareness Week is supported by Amgen, Immunovant, Inc., Tourmaline Bio, Inc. and Viridian Therapeutics, according to the announcement.
By Staff
Friday, November 15, 2024 12:27 AM
NEW YORK—The national average for gross revenue at ECP locations remained flat last week, November 4–10, when compared with the previous week. That places gross revenue at a level 17 index points above where it was at this point in time (Week 45) when compared with last year (2023), 18 points above the same period in 2022, 28 points above 2021, 21 points above 2020 and 28 points above 2019, according to Jobson’s most recent Practice Performance Tracker.
By Staff
Friday, November 15, 2024 12:24 AM
MIAMI—
Innovative Eyewear Inc. (NASDAQ: LUCYW) has announced its financial results for the third quarter of 2024, demonstrating net revenue of $253,599 for the quarter ended September 30, 2024, an increase of 14 percent from the same period last year.
By Staff
Friday, November 15, 2024 12:21 AM
NASHVILLE, Tenn.—
Harrow (Nasdaq: HROW), a North American eyecare pharmaceutical company, announced results for the third quarter ended September 30, 2024, reporting that revenues for the third quarter of 2024 were $49.3 million.
By Staff
Friday, November 15, 2024 12:18 AM
BEDFORD, Mass.—
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company developing therapies for retinal diseases and other eye conditions, reported financial results for the third quarter ended September 30, 2024.
By Staff
Friday, November 15, 2024 12:15 AM
NEWARK, N.J.—
Registration is open for VM's 2025 Leadership Summit, which will be held in Orlando, Fla., on Wednesday, February 19, just ahead of Vision Expo East. The program for the VM Summit is titled, "Elevating Vision Care’s Superpowers. Collaborations Drive New Tech and Innovation." Early bird tickets and registration have a deadline of 11:59 p.m. ET on December 6. “We're excited to open registration for the 2025 Leadership Summit," said Anne Cooper, editorial director of
Vision Monday and
20/20.